Inside informationEnglish
A transitional half-year marked by the ongoing sale of Myrian and Intrasense’s strategic repositioning toward its DUOnco™ artificial intelligence solutions dedicated to oncology
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Intrasense
- Filed
- 23/07/2026, 18:03
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 638869_20260723